Nektar Therapeutics (NKTR) Short Interest Ratio & Short Volume $25.84 +0.08 (+0.31%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Nektar Therapeutics Short Interest DataNektar Therapeutics (NKTR) has a short interest of 595,800 shares, representing 4.98% of the float (the number of shares available for trading by the public). This marks a -20.95% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 449,772 shares to cover all short positions.Current Short Interest595,800 sharesPrevious Short Interest753,700 sharesChange Vs. Previous Month-20.95%Dollar Volume Sold Short$5.12 millionShort Interest Ratio0.5 Days to CoverLast Record DateJune 15, 2025Outstanding Shares12,410,000 sharesFloat Size11,960,000 sharesShort Percent of Float4.98%Today's Trading Volume2,446,682 sharesAverage Trading Volume449,772 sharesToday's Volume Vs. Average544% Short Selling Nektar Therapeutics? Sign up to receive the latest short interest report for Nektar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNKTR Short Interest Over TimeNKTR Days to Cover Over TimeNKTR Percentage of Float Shorted Over Time Nektar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025595,800 shares $5.12 million -21.0%5.0%0.5 $8.59 5/31/2025753,700 shares $8.18 million -92.9%0.4%4.4 $10.85 5/15/202510,660,000 shares $7.25 million +19.4%5.9%5.2 $0.68 4/30/20258,930,000 shares $7.10 million +9.7%5.0%3.6 $0.80 4/15/20258,140,000 shares $5.19 million +4.8%4.5%3.4 $0.64 3/31/20257,770,000 shares $5.28 million +11.8%4.3%3.5 $0.68 3/15/20256,950,000 shares $6.23 million +5.0%3.9%3.5 $0.90 2/28/20256,620,000 shares $5.58 million -11.5%3.7%3.1 $0.84 2/15/20257,480,000 shares $7.35 million +29.9%4.2%3.4 $0.98 1/31/20255,760,000 shares $4.77 million +22.0%3.2%3 $0.83 Get the Latest News and Ratings for NKTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20254,720,000 shares $4.27 million +8.5%2.7%2.6 $0.91 12/31/20244,350,000 shares $4.05 million -1.1%2.5%2.4 $0.93 12/15/20244,400,000 shares $4.44 million -0.9%2.5%2.5 $1.01 11/30/20244,440,000 shares $5.06 million -13.5%2.5%2.7 $1.14 11/15/20245,130,000 shares $5.49 million -1.9%2.9%3.7 $1.07 10/31/20245,230,000 shares $6.22 million -13.4%2.9%4.4 $1.19 10/15/20246,040,000 shares $7.79 million -17.4%3.4%5.9 $1.29 9/30/20247,310,000 shares $9.50 million -5.8%4.1%7.1 $1.30 9/15/20247,760,000 shares $10.17 million -5.8%4.4%5.2 $1.31 8/31/20248,240,000 shares $10.55 million -2.7%4.6%5.2 $1.28 8/15/20248,470,000 shares $10.08 million -4.1%4.8%4.9 $1.19 7/31/20248,830,000 shares $11.83 million -9.2%4.9%4.7 $1.34 7/15/20249,720,000 shares $13.61 million +140.0%5.4%5 $1.40 6/30/20244,050,000 shares $5.02 million -6.7%2.3%1.7 $1.24 6/15/20244,340,000 shares $5.08 million +58.4%2.4%1.9 $1.17 5/31/20242,740,000 shares $3.48 million +3.4%1.5%1.3 $1.27 5/15/20242,650,000 shares $4.85 million -25.1%1.5%1 $1.83 4/30/20243,540,000 shares $5.17 million +13.8%2.0%1.4 $1.46 4/15/20243,110,000 shares $4.88 million +31.8%1.8%1.3 $1.57 3/31/20242,360,000 shares $2.20 million -6.0%1.3%1.2 $0.93 3/15/20242,510,000 shares $2.16 million +24.9%1.4%1.6 $0.86 2/29/20242,010,000 shares $1.43 million -18.0%1.1%1.2 $0.71 2/15/20242,450,000 shares $1.81 million -57.8%N/A2 $0.74 1/31/20245,800,000 shares $3.15 million +6.6%N/A4.8 $0.54 1/15/20245,440,000 shares $2.91 million +1.7%N/A3.7 $0.53 12/31/20235,350,000 shares $3.02 million -23.1%N/A3.4 $0.57 12/15/20236,960,000 shares $3.26 million -3.7%N/A4.5 $0.47 11/30/20237,230,000 shares $3.54 million -9.7%N/A4.6 $0.49 11/15/20238,010,000 shares $4.21 million +7.2%N/A4.7 $0.53 10/31/20237,470,000 shares $3.50 million -8.8%N/A2.8 $0.47"I'm risking my reputation on this" (Ad)Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.Claim your FREE copy of Crypto Revolution now. 10/15/20238,190,000 shares $4.41 million +5.8%N/A1.4 $0.54 9/30/20237,740,000 shares $4.61 million +6.6%N/A1.3 $0.60 9/15/20237,260,000 shares $5.12 million +7.1%N/A1.2 $0.71 8/31/20236,780,000 shares $4.03 million -5.2%N/A1 $0.60 8/15/20237,150,000 shares $5.79 million +23.3%N/A1 $0.81 7/31/20235,800,000 shares $3.11 million +9.9%N/A0.9 $0.54 7/15/20235,280,000 shares $2.90 million -2.8%N/A1.5 $0.55 6/30/20235,430,000 shares $3.12 million -50.8%N/A1.4 $0.58 6/15/202311,030,000 shares $6.23 million +11.5%N/A2 $0.56 5/31/20239,890,000 shares $5.74 million -2.1%N/A2 $0.58 5/15/202310,100,000 shares $7.71 million +5.4%N/A2 $0.76 4/30/20239,580,000 shares $7.21 million +16.7%5.8%2 $0.75 4/15/20238,210,000 shares $7.60 million -3.5%N/A1.7 $0.93 3/31/20238,510,000 shares $5.98 million +20.2%N/A1.9 $0.70 3/15/20237,080,000 shares $8.07 million -19.1%N/A2.9 $1.14 2/28/20238,750,000 shares $12.08 million -11.8%N/A4.5 $1.38 2/15/20239,920,000 shares $30.85 million -0.1%N/A4.9 $3.11 1/31/20239,930,000 shares $27.01 million +7.7%N/A6.1 $2.72 1/15/20239,220,000 shares $23.23 million +2.4%N/A5.9 $2.52 12/30/20229,000,000 shares $20.34 million -1.6%N/A5.6 $2.26 12/15/20229,150,000 shares $24.71 million -44.4%N/A5.3 $2.70 11/30/202216,470,000 shares $46.12 million -1.9%N/A9 $2.80 11/15/202216,790,000 shares $65.82 million -3.2%N/A10.6 $3.92 10/31/202217,350,000 shares $65.24 million -0.2%N/A10.6 $3.76 10/15/202217,390,000 shares $61.73 million -0.6%N/A9.5 $3.55 9/30/202217,500,000 shares $56 million -0.5%N/A7.7 $3.20 9/15/202217,590,000 shares $64.38 million -0.2%N/A6.5 $3.66 8/31/202217,630,000 shares $69.46 million -6.5%N/A6.1 $3.94 8/15/202218,860,000 shares $92.60 million -0.7%N/A6.1 $4.91 7/31/202219,000,000 shares $75.24 million -19.4%N/A5.7 $3.96 7/15/202223,560,000 shares $84.34 million +17.1%N/A6.6 $3.58 6/30/202220,120,000 shares $76.46 million +14.1%N/A5.2 $3.80 6/15/202217,640,000 shares $59.27 million -1.2%N/A4.4 $3.36 5/31/202217,860,000 shares $62.15 million -1.3%N/A4.2 $3.48 5/15/202218,100,000 shares $72.22 million -1.3%N/A4.4 $3.99 4/30/202218,330,000 shares $75.70 million -10.3%N/A4.7 $4.13 4/15/202220,430,000 shares $125.85 million -2.3%N/A5.6 $6.16 3/31/202220,920,000 shares $112.76 million -12.1%N/A7 $5.39 3/15/202223,790,000 shares $106.58 million +11.5%N/A8.6 $4.48 2/28/202221,330,000 shares $218.42 million +3.6%N/A8.3 $10.24 2/15/202220,580,000 shares $230.08 million +4.7%11.4%8.2 $11.18 1/31/202219,660,000 shares $218.62 million +6.3%10.8%7.8 $11.12 1/15/202218,500,000 shares $223.85 million -2.5%10.2%7.6 $12.10 12/31/202118,980,000 shares $256.42 million +11.3%10.4%8.7 $13.51 12/15/202117,060,000 shares $221.10 million +5.7%9.4%8.4 $12.96 11/30/202116,140,000 shares $181.74 million -4.0%8.9%12.1 $11.26 11/15/202116,820,000 shares $224.38 million +3.2%9.2%14.9 $13.34 10/29/202116,300,000 shares $247.11 million +1.6%9.0%15.8 $15.16 10/15/202116,040,000 shares $277.65 million -0.9%8.8%18.7 $17.31 9/30/202116,190,000 shares $290.77 million -1.8%8.9%18.9 $17.96"I'm risking my reputation on this" (Ad)Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.Claim your FREE copy of Crypto Revolution now. 9/15/202116,480,000 shares $266.65 million -5.0%9.1%19 $16.18 8/31/202117,350,000 shares $268.58 million -1.5%9.6%20.4 $15.48 8/13/202117,620,000 shares $251.79 million -2.0%9.7%20.9 $14.29 7/30/202117,970,000 shares $283.75 million +0.7%10.0%21 $15.79 7/15/202117,840,000 shares $295.97 million -1.8%9.9%19.8 $16.59 6/30/202118,160,000 shares $311.63 million -0.8%10.1%20 $17.16 6/15/202118,310,000 shares $325.00 million +1.5%10.2%20.8 $17.75 5/28/202118,040,000 shares $325.98 million -0.4%10.0%20.7 $18.07 5/14/202118,110,000 shares $341.55 million -5.9%N/A19.9 $18.86 4/30/202119,240,000 shares $386.53 million -2.2%N/A18.2 $20.09 4/15/202119,680,000 shares $376.68 million +2.1%N/A16 $19.14 3/31/202119,280,000 shares $376.15 million -3.3%N/A15.3 $19.51 3/15/202119,940,000 shares $455.03 million -6.2%N/A14.9 $22.82 2/26/202121,250,000 shares $476.85 million +0.4%N/A15.9 $22.44 2/12/202121,160,000 shares $481.39 million -7.6%N/A16.7 $22.75 1/29/202122,900,000 shares $422.28 million -4.5%N/A19.4 $18.44 1/15/202123,970,000 shares $426.67 million -1.0%N/A22.6 $17.80 12/31/202024,200,000 shares $434.15 million -1.5%N/A24 $17.94 12/15/202024,560,000 shares $433.24 million -0.3%N/A23.8 $17.64 11/30/202024,640,000 shares $413.71 million -0.2%N/A23.7 $16.79 11/15/202024,700,000 shares $426.57 million -2.1%N/A22.9 $17.27 10/30/202025,240,000 shares $409.14 million -2.5%N/A23.8 $16.21 10/15/202025,890,000 shares $454.11 million +1.7%N/A26.4 $17.54 9/30/202025,470,000 shares $422.55 million -1.3%N/A27.5 $16.59 9/15/202025,800,000 shares $516.26 million -1.7%N/A28.3 $20.01 8/31/202026,240,000 shares $507.48 million -0.7%N/A29 $19.34 8/14/202026,420,000 shares $516.51 million -1.3%N/A27.5 $19.55 7/31/202026,770,000 shares $593.22 million +0.1%N/A26 $22.16 7/15/202026,740,000 shares $630.80 million -2.3%N/A24.5 $23.59 NKTR Short Interest - Frequently Asked Questions What is Nektar Therapeutics' current short interest? Short interest is the volume of Nektar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 595,800 shares of NKTR short. 4.98% of Nektar Therapeutics' shares are currently sold short. Learn More on Nektar Therapeutics' current short interest. Which institutional investors are shorting Nektar Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Nektar Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Nektar Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.98% of Nektar Therapeutics' floating shares are currently sold short. Is Nektar Therapeutics' short interest increasing or decreasing? Nektar Therapeutics saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 595,800 shares, a decline of 20.9% from the previous total of 753,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nektar Therapeutics' float size? Nektar Therapeutics currently has issued a total of 12,410,000 shares. Some of Nektar Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nektar Therapeutics currently has a public float of 11,960,000 shares. How does Nektar Therapeutics' short interest compare to its competitors? 4.98% of Nektar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Nektar Therapeutics: Pacira BioSciences, Inc. (12.92%), Omeros Corporation (23.40%), Assembly Biosciences, Inc. (0.41%), Cumberland Pharmaceuticals Inc. (0.82%), Eli Lilly and Company (0.94%), Johnson & Johnson (0.68%), AbbVie Inc. (0.84%), Merck & Co., Inc. (1.43%), Pfizer Inc. (1.88%), Bristol Myers Squibb Company (1.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Nektar Therapeutics stock? Short selling NKTR is an investing strategy that aims to generate trading profit from Nektar Therapeutics as its price is falling. NKTR shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nektar Therapeutics? A short squeeze for Nektar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NKTR, which in turn drives the price of the stock up even further. How often is Nektar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NKTR, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies PCRX Short Interest OMER Short Interest ASMB Short Interest CPIX Short Interest LLY Short Interest JNJ Short Interest ABBV Short Interest MRK Short Interest PFE Short Interest BMY Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NKTR) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
